R2V-26921-07222
2 vaccinations
2 coded responses
19 check-ins
2 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 430 / OH
- Registered
- 2022-07-05
- Relationship
- Child or adolescent in my care
- Guardian
- N55-14026-35465
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-05
Registered in v-safe
-
2022-07-05
Dose 1 — Pfizer-BioNTech
- 2022-07-05
- 2022-07-06
- 2022-07-07
- 2022-07-09
- 2022-07-10
- 2022-07-11
- 2022-07-14
- 2022-07-19
-
2022-07-26
Dose 2 — Pfizer-BioNTech
- 2022-07-27
- 2022-07-28
- 2022-07-29
- 2022-07-30
- 2022-07-31
- 2022-08-02
- 2022-08-09
-
2022-08-16
Survey response — day 21, dose 2, under 3MedDRA: Cough, Respiratory tract congestion, Rhinorrhoea, Sneezing — Feeling: Fair · Be unable to work or attend schoolFree text: Congestion, runny nose, cough, sneezingMedDRA releases: 2024-11 · check-in free text available
- 2022-08-23
- 2022-08-30
-
2022-09-06
Survey response — day 42, dose 2, under 3MedDRA: Cough, Decreased appetite, Diarrhoea, Fatigue, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Congestion, runny nose, some coughing, diarrhea, low appetite, fatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-09-06
Report sent to call center — day 42, dose 2, under 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-09-07
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-05 | Pfizer-BioNTech | No |
| 2 | 2022-07-26 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 12 (Under 3) — day 21, dose 2, under 3
Symptoms: Congestion, runny nose, cough, sneezing
Release 12 (Under 3) — day 42, dose 2, under 3
Symptoms: Congestion, runny nose, some coughing, diarrhea, low appetite, fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release